Alvaiz

Active Ingredient(s): Eltrombopag Choline
FDA Approved: * November 29, 2023
Pharm Company: * TEVA PHARMS
Category: Blood Clotting (Hemostasis)

Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. Promacta (eltrombopag) is known as Revolade® outside the U.S. and is marketed worldwide by Novartis.[5] It is a thrombopoietin receptor agonist.[3] Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals and is transferred to Nova... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Alvaiz 9 mg Oral Tablet, Film Coated
NDC: 0480-3273
Labeler:
Teva Pharmaceuticals, Inc.
Alvaiz 18 mg Oral Tablet, Film Coated
NDC: 0480-3274
Labeler:
Teva Pharmaceuticals, Inc.
Alvaiz 36 mg Oral Tablet, Film Coated
NDC: 0480-3275
Labeler:
Teva Pharmaceuticals, Inc.
Alvaiz 54 mg Oral Tablet, Film Coated
NDC: 0480-3276
Labeler:
Teva Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients